期刊文献+

多药耐药与子宫内膜癌化疗现状 被引量:1

下载PDF
导出
出处 《陕西医学杂志》 CAS 北大核心 2003年第11期1008-1010,共3页 Shaanxi Medical Journal
  • 相关文献

参考文献15

  • 1梁利波,马业伟,周小山,杨军,李艳春,王争,周兰萍,章扬培,赵清正.特异启动子调控的MDR1和MnSOD基因对骨髓的选择性保护作用[J].中华肿瘤杂志,2003,25(1):17-20. 被引量:2
  • 2Jemal A, Thomas A, Murray T, et a. Cancer statistics,2002. CA Cancer J Clin ,2002,52 : 23. 被引量:1
  • 3Elit L, Hirte H. Current status and future innovations of hormonal agents chemotheraphy and investigational agents in endometrial cancer. Curr Opin Obstet Gynecol, 2002,14(1) : 67. 被引量:1
  • 4Bielder JL, Riehm H. Celluar resistance to actionmycin in Chinese hamster ceils in vitro: crossresistance radioautographic and cytogenetic studies.Cancer Res, 1970,30 : 1174. 被引量:1
  • 5Ling V. Multidrug resistance: Moleculer mechanisms and clinical relevance. Cancer Chemother Pharmaco, 1997 , 40(suppl) : 3. 被引量:1
  • 6Kodama J, Ryoji H, Okuda H, et al. Reverse correlation between P-gp and proliferative activity in endometrial adenocarcinoma. Eur J Obstet Gynecol Reprod Biol, 1995,59 : 45. 被引量:1
  • 7Kigawa J, Sato S, Shimada M,et al. P53 gene status and chemosensitivity in ovarian cancer. Hum Cell, 2001,14(3) : 165. 被引量:1
  • 8Inoue T, Sullivan FX, Cech TR, et al.Intermolecular exon ligation of the rRNA precursor of Tetrahymena. oligonucleotides can function as 5'exons. CeU, 1985,43(2 Pt 1): 7. 被引量:1
  • 9Ball HG, Blessing JA, Lentz SS, et al. A phase Ⅱ trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol, 1996, 62(2) : 278. 被引量:1
  • 10Gebbia V, Testa A, Borsellino N, et al. Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium :a new highly active chemotherapeutic regimen. Ann Oncol,2001,12(6): 72. 被引量:1

二级参考文献4

共引文献1

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部